Pancreatic Cancer Research

ResearcherVA Greater Los Angeles Healthcare SystemNo recent work listed

James Steven Tomlinson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8815-0518; OpenAlex author ID A5069362975. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper

Papers 2

  1. A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts. Last author DOI 10.1007/s11307-014-0733-4↗
  2. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles. Last author DOI 10.1016/j.jss.2013.05.095↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna M Wu · 2 shared papers, 2013–2014 · strength 0.09
  2. Mark D. Girgis MD · 2 shared papers, 2013–2014 · strength 0.09
  3. Matthew M. Rochefort · 2 shared papers, 2013–2014 · strength 0.09
  4. Jacob S. Ankeny · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.